Sponsored by:

Molecular Imaging: Page 427

SPECT MPI predicts sudden cardiac death
By Wayne Forrest
A new study concluded that myocardial perfusion imaging (MPI) is a significant predictor of sudden cardiac death. The results also indicate that gated SPECT imaging may represent a more effective means of risk stratification than solitary left ventricular ejection fraction determination.
September 25, 2008
IBA to develop PET market in South Korea
By AuntMinnie.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) has inked an agreement with a South Korean firm to market PET radiopharmaceuticals in that country.
September 24, 2008
Covidien gets FDA warning letter
By AuntMinnie.com staff writers
Radiopharmaceutical firm Covidien has received a warning letter from the U.S. Food and Drug Administration for manufacturing issues at a plant that produces the company's Ultra-TechneKow-DTE technetium-99m-based product.
September 24, 2008
IBA adds MI order
By AuntMinnie.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) has received another proton therapy system order from ProCure Proton Therapy Center at William Beaumont Hospital in Royal Oak, MI.
September 23, 2008
Philips, University of Urbino ink contrast deal
By AuntMinnie.com staff writers
Philips Healthcare sister unit Philips Research and the University of Urbino in Italy have signed a research agreement to study the development of long-retention-time contrast agents.
September 23, 2008
Lantheus to license Bracco's CardioGen PET tracer
By AuntMinnie.com staff writers
Lantheus Medical Imaging has signed a deal to license the CardioGen-82 rubidium-82 PET radiopharmaceutical from Bracco Diagnostics.
September 23, 2008
Covidien launches generic Cardiolite
By AuntMinnie.com staff writers
Radiopharmaceutical firm Covidien has launched a generic version of Cardiolite, the technetium sestamibi radiopharmaceutical for SPECT myocardial perfusion imaging.
September 22, 2008
Philips shows integrated oncology suite
By AuntMinnie.com staff writers
Philips Healthcare is highlighting an integrated oncology suite at the American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting.
September 22, 2008
IBA nets proton therapy order
By AuntMinnie.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) said it will be providing a proton therapy system at the upcoming Proton Therapy Center at Central DuPage Hospital in Winfield, IL.
September 22, 2008
Digirad gets FDA nod for nSpeed
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad has received U.S. Food and Drug Administration 510(k) clearance for its nSpeed reconstruction software.
September 22, 2008
Proton therapy lowers chance of second malignancy
By Wayne Forrest
BOSTON - A study from Massachusetts General Hospital concluded that proton therapy decreases the risk of cancer patients developing a second malignancy by 50%, compared to treatment with standard photon radiation. Findings were detailed on Monday at the American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting.
September 22, 2008
Calypso, Siemens join forces
By AuntMinnie.com staff writers
Electromagnetic localization developer Calypso Medical Technologies and Siemens Healthcare have signed a product collaboration agreement to integrate Calypso's real-time tumor tracking data with Siemens' linear accelerator products.
September 21, 2008
Previous Page
Page 427 of 616
Next Page